HEIDELBERG PHARMA GMBH has a total of 105 patent applications. It increased the IP activity by 133.0%. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BERLIN CHEMIE AG, ADC THERAPEUTICS SARL and SICHUAN BAILI PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 12 | |
#3 | China | 10 | |
#4 | Mexico | 7 | |
#5 | Australia | 6 | |
#6 | Brazil | 6 | |
#7 | Canada | 6 | |
#8 | New Zealand | 6 | |
#9 | Singapore | 6 | |
#10 | Israel | 5 | |
#11 | Republic of Korea | 5 | |
#12 | South Africa | 5 | |
#13 | Hong Kong | 4 | |
#14 | Ukraine | 4 | |
#15 | United States | 4 | |
#16 | Argentina | 1 | |
#17 | Hungary | 1 | |
#18 | Japan | 1 | |
#19 | Norway | 1 | |
#20 | Slovenia | 1 | |
#21 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Simon Werner | 59 |
#2 | Lutz Christian | 58 |
#3 | Anderl Jan | 49 |
#4 | Mueller Christoph | 39 |
#5 | Hechler Torsten | 26 |
#6 | Müller Christoph | 19 |
#7 | Muller Christoph | 18 |
#8 | Werner Simon | 14 |
#9 | Jan Anderl | 11 |
#10 | Christian Lutz | 11 |
Publication | Filing date | Title |
---|---|---|
CN111051310A | Novel method for synthesizing amanitin | |
EP3546447A1 | Synthesis of (2s,3r,4r)-4,5-dihydroxyisoleucine and derivatives | |
EP3222292A1 | Amanitin conjugates | |
CN105377304A | Amatoxin derivatives | |
EP2774624A1 | Amatoxin derivatives | |
EP2684865A1 | Methods for synthesizing amatoxin building block and amatoxins | |
EP2497499A1 | Amatoxin-conjugates with improved linkages | |
EP2436398A1 | Amatoxin-conjugates with improved linkers | |
US2008014258A1 | Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases | |
WO2006122716A1 | Use of ether-linked lysophosphatidylcholines and alkylphosphocholines for the treatment of papilloma virus induced warts and sarcoids | |
WO2006082053A1 | 7-ethyl-10-hydroxy-camptothecin lipid ester derivatives |